• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Impact of Precision Medicine| News, Policy, Analysis, Insights - HIT Consultant

Vanderbilt University Medical Center to Create A Precision Medicine Trial Network Focused on Critical Illness

by Fred Pennic 09/28/2020 Leave a Comment

Vanderbilt University Medical Center to Create Precision Medicine Trial Network Focused on Critical Illness

What You Should Know: - Vanderbilt University Medical Center inks a strategic partnership with Endpoint Health to create the world’s first precision medicine trial network focused on critical illness. - Late-stage interventional trials will evaluate personalized approaches to existing care and novel targeted therapies. Vanderbilt University Medical Center (VUMC) and Endpoint Health, the first targeted therapeutics company focused on integrated solutions for critical illnesses, today
Read More

Syapse Appoints David Pomerantz as Chief Commercial Officer

by Jasmine Pennic 09/03/2020 Leave a Comment

Syapse Appoints David Pomerantz as Chief Commercial Officer

Syapse, a real-world evidence company accelerating the delivery of precision medicine through the Syapse Learning Health Network™, today announced the appointment of David Pomerantz as Chief Commercial Officer. In his new role as Chief Commercial Officer, Pomerantz will lead the future direction of Syapse’s commercial endeavors and expand its life sciences partnerships across the Syapse Learning Network. Pomerantz Bio/Background Mr. Pomerantz brings more than 25 years of account
Read More

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

by Jasmine Pennic 08/11/2020 Leave a Comment

FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer

What You Should Know: The FDA and Syapse announce research collaboration expansion to address urgent public health challenges including supporting FDA’s goal of rapid understanding of COVID-19. As part of the research, Syapse is partnering with FDA’s Oncology Center of Excellence to investigate methods to derive RWD from multiple sources including electronic health records, registries and molecular data Syapse, a real-world evidence company accelerating the delivery of precision
Read More

M&A Analysis: 3 Benefits of Siemens Healthineers’ $16.4B Acquisition of Varian Medical

by Steve Holloway, Director at Signify Research 08/07/2020 Leave a Comment

M&A Analysis: 3 Benefits of Siemens Healthineers $16.4B Acquisition of Varian Medical

What You Should Know: - Siemens Healthineers and Varian Medical announce a $16.4B deal in an all-cash transaction on 2nd August 2020. - Deal expected to close in 1H 2021. - Varian Medical will maintain its brand name and operate “independently” - Siemens AG will drop holding in Siemens Healthineers from 85% to 72% as part of the transaction. News of the deal between Siemens Healthineers and Varian Medical will have caught many industry onlookers off guard on Sunday evening.
Read More

HHS Taps Fenway Health as Pilot Site for Precision Medicine Project

by Jasmine Pennic 07/14/2020 Leave a Comment

HHS Taps Fenway Health as Pilot Site for Advancing Standards for Precision Medicine Project

What You Should Know: - Fenway Health has been selected as the pilot site to participate in the Advancing Standards for Precision Medicine (ASPM) project. - The ASPM project is focused on how healthcare providers can systematically identify the socio-economic factors that may impact the health of patients in order to provide more individualized care that reflects patients’ needs.  Fenway Health, a Boston, MA-based Federally Qualified Community Health Center (FQCHC)
Read More

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

by Joel Diamond, MD, FAAFP, Chief Medical Officer at 2bPrecise 06/09/2020 Leave a Comment

Consumer Genetic Tests Accelerate Precision Medicine for Some Providers

Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications. Like many such advances, availability of DTC tests is
Read More

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

by Fred Pennic 05/28/2020 Leave a Comment

Syapse Lands $30M to Accelerate Real-World Evidence in Oncology

What You Should Know: - Syapse raises $30M in new equity funding to enable healthcare providers to deliver the best care to every cancer patient through precision medicine. - Syapse partners with health systems, life sciences companies, and regulators to deliver clinical, programmatic, and research insights from the world’s largest network of health systems focused on precision medicine. Syapse, a San Francisco, CA-based provider of precision oncology solutions announced $30
Read More

AHA Launches COVID-19 Data Challenge to Address Health Disparities Among African Americans, Hispanics, Native Americans in Rural Areas

by Fred Pennic 05/15/2020 Leave a Comment

AHA Launches COVID-19 Data Challenge to Address Health Disparities Among African Americans, Hispanic, Native Americans in Rural Areas

What You Need to Know: - American Heart Association, Hitachi Vantara and BurstIQ launch COVID-19 Data Challenge to bring global COVID-19 datasets to researchers and clinicians to examine the relationship with other health conditions and health disparities. - Each participant of the challenge will be provided a free, HIPPA compliant and FedRAMP certified, secure Precision Medicine Platform (PMP) workspace to conduct analyses. The American Heart Association, the
Read More

The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health

by Fred Pennic 05/13/2020 Leave a Comment

The DNA Company Acquires AI Digital Therapeutics App for $30M to Form My Next Health

What You Should Know: - DNA Company acquires AI-based digital therapeutics app My Pain Sensei (MPS) to form My Next Health and is building a COVID-19 risk assessment platform to help people understand their risks of developing serious COVID-19 complications.  - The acquisition combines functional genomics with conversational AI for patient self-management apps and disease tracking tools designed to inform clinician-patient interactions. Leading functional genomics provider The
Read More

Machine Learning Will Transform Medicine, but Only if We Use it Right

by Natalie LaFranzo, PhD is VP, Market Development of Cofactor Genomics 05/12/2020 Leave a Comment

Natalie LaFranzo

World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer. It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 8
  • Go to page 9
  • Go to page 10
  • Go to page 11
  • Go to page 12
  • Interim pages omitted …
  • Go to page 22
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

White House Event Unveils CMS Health Tech Ecosystem Initiative

White House Event Unveils CMS Health Tech Ecosystem Initiative

Meaningful Use Penalties_Meaningful Use_Partial Code Free_Senators Urge CMS to Establish Clear Metrics for ICD-10 Testing

CMS Finalizes TEAM Model: A New Era of Value-Based Surgical Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |